Overview of Assets


Our Assets give investors access to life sciences businesses with unique exposure across diverse modalities, therapeutic areas and geographies.

Our assets are largely maturing clinical development or commercial companies, nearing significant value inflection or realisation points, in which we hold meaningful stakes.

Our Assets


Our strategic objective is to support value creation in our investee companies.

We offer investors access to companies with compelling value propositions spanning innovation across multiple areas of healthcare. Our investee companies are at the forefront of cutting-edge technological advancement in their fields and have the required talent and technical expertise to deliver profound healthcare improvements to patients around the world.

Malin Equity: 5%

Discover more

Malin Equity: 15%

Discover more

Malin Equity: 15%

Discover more

4 Growth Potential Assets


We will continue to support the progression of these assets as they target important strategic, scientific and operational milestones.

Early-stage assets

Revenue generative assets

Malin Equity: 12%

Discover more

Malin Equity: 11%

Discover more

Malin Equity: 65%

Discover more